2012
DOI: 10.5504/bbeq.2011.0151
|View full text |Cite
|
Sign up to set email alerts
|

Differential Genetic Advantages in Youth and in Aging, or How to Die Healthy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 87 publications
(71 reference statements)
0
10
0
Order By: Relevance
“…It soon became clear that the strength of the associations of these polymorphisms with human diseases and conditions may be very different in different populations, and in individuals at different ages. While the former could among other things, reflect population-specific intra-genomic interferences between alternative alleles at different loci, the latter was less straightforward and was attributed by some authors to the phenomenon of 'antagonistic pleiotropy', that is the case of one genetic trait being beneficial at early age but deleterious at a later age or vice versa (Khalil et al 2012a, Chakarov et al 2014a). There was one notable case in which the same allele of a single-nucleotide polymorphism (ERCC1 C8092A) was associated with opposite effects on the survival of patients with the same disease treated with the same type of agents in two independent large studies (Zhou 2004, Kalikaki et al 2009).…”
Section: Methodologies Of Irc Assessment -Typing Polymorphisms May Nomentioning
confidence: 99%
“…It soon became clear that the strength of the associations of these polymorphisms with human diseases and conditions may be very different in different populations, and in individuals at different ages. While the former could among other things, reflect population-specific intra-genomic interferences between alternative alleles at different loci, the latter was less straightforward and was attributed by some authors to the phenomenon of 'antagonistic pleiotropy', that is the case of one genetic trait being beneficial at early age but deleterious at a later age or vice versa (Khalil et al 2012a, Chakarov et al 2014a). There was one notable case in which the same allele of a single-nucleotide polymorphism (ERCC1 C8092A) was associated with opposite effects on the survival of patients with the same disease treated with the same type of agents in two independent large studies (Zhou 2004, Kalikaki et al 2009).…”
Section: Methodologies Of Irc Assessment -Typing Polymorphisms May Nomentioning
confidence: 99%
“…At the same time, carriership of the variant allele of the rs929271 LIF polymorphism was reported to be associated with increased ongoing pregnancy rates after IVF [93]. Apparently, carriership of this polymorphic allele may be associated with adverse effects on female fertility in young age and a beneficial effect at later age and/or after IVF, that is, it may represent an example of antagonistic pleiotropy [94].…”
Section: Reproductive Outcomes and Individual Repair Capacitymentioning
confidence: 99%
“…it has been demonstrated, however, that individuals with homozygous R/R genotypes may have poorer outcomes after incidents of acute ischaemia, which is most likely related to the proneness of damaged R/R cells to apoptosis compared to cells with P/R and P/P genotypes (1,25). Apparently, the process of physiological aging as well as the process of development of disease may serve as tipping points in the balance between the pro-transactivation and the pro-apoptotic properties of p53, with consequences dependent on the combined impact of other factors (35,72).…”
Section: P53mentioning
confidence: 99%
“…it has been shown in murine models, however, that constitutively high levels of the non-cancerous isoforms of p53 are associated with a striking phenotype of premature aging (24). it is believed that the aging is a major anticancer mechanism that p53 deploys in order to ensure that cells at high risk of significant alterations in their DnA are systematically and safely removed from the replicative pool (10,35,57).…”
Section: P53mentioning
confidence: 99%
See 1 more Smart Citation